11-108335098-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000051.4(ATM):c.8140C>T(p.Gln2714*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,776 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000051.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.8140C>T | p.Gln2714* | stop_gained | Exon 55 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461776Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727184
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek 2016); Observed in individuals with breast cancer (Renault 2018); This variant is associated with the following publications: (PMID: 25525159, 15280931, 15101044, 8845835, 15390180, 12745884, 14970866, 29665859) -
- -
- -
Familial cancer of breast Pathogenic:3
- -
- -
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
Breast and/or ovarian cancer Pathogenic:1
- -
Ataxia-telangiectasia syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln2714*) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with ataxia-telangiectasia (PMID: 8845835). ClinVar contains an entry for this variant (Variation ID: 419265). For these reasons, this variant has been classified as Pathogenic. -
Gastric cancer Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Q2714* pathogenic mutation (also known as c.8140C>T), located in coding exon 54 of the ATM gene, results from a C to T substitution at nucleotide position 8140. This changes the amino acid from a glutamine to a stop codon within coding exon 54. This alteration has reported in the homozygous and compound heterozygous state in individuals diagnosed with ataxia telangiectasia (Gilad S et al. Hum. Mol. Genet. 1996 Apr;5:433-9; Cavaciuti E et al. Genes Chromosomes Cancer 2005 Jan;42:1-9). Functional studies have demonstrated increased radiosensitivity and decreased mRNA expression in cell lines containing this alteration in the homozygous/compound heterozygous state or heterozygous state (Fernet M et al. Int. J. Radiat. Biol., 2003 Mar;79:193-202; Gutiérrez-Enríquez S et al. Genes Chromosomes Cancer 2004 Jun;40:109-19). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at